Skip to content
Altius – Lifestyle
Author:
Seismic Pharmaceuticals
/UPDATE — Seismic Pharmaceuticals/
September 9, 2026
Seismic Pharmaceuticals Commences Global Phase 3 Trial of Istaroxime in Patients With Cardiogenic Shock
September 9, 2026
MEMORIAL HEALTHCARE SYSTEM REPORTS 178% SURGE IN E-BIKE & E-SCOOTER INJURIES
May 6, 2026
Panacea Capital Leads Formation of Seismic Pharma to Advance Novel, Clinical-Stage Heart Failure Portfolio
March 30, 2026